[Comment] 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

In the paediatric oncology community, there was great hope and expectation that the European Commission report, State of Paediatric Medicines in the EU —10 years of the EU Paediatric Regulation,1 might suggest major alterations in the landscape of development of new drugs for children's cancers. Have these expectations been met?

Source: The Lancet Oncology - March 1, 2018 Category: Cancer & Oncology Authors: Andrew DJ Pearson, Delphine Heenen, Pamela R Kearns, Anne Goeres, Lynley V Marshall, Patricia Blanc, Gilles Vassal Tags: Comment Source Type: research